Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CXCR4-Targeted PET Imaging in Cushing's Syndrome
NCT07350707Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Dec 2025
- Primary completion
- Nov 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentixafor in Cushing's syndrome, sponsored by Peking Union Medical College Hospital. Started Dec 2025; status: recruiting.
02
Drugs
pentixafor
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT07350707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07350707.